PO-1059: Octaarginine Modified Gold Nanoparticles Enhance the Radiosensitivity of Colorectal Cancer Cell

X. Zhang,R. Yang,H. Wang

DOI: https://doi.org/10.1016/s0167-8140(18)31369-0

IF: 6.901

2018-01-01

Radiotherapy and Oncology

Abstract:ESTRO 37 S594 molecules (p-ATM), and VEGF-A expression were assessed both in vitro and in vivo. ResultsRT+BEZ+mBEZ group significantly inhibited cell viability and increased apoptosis (cleaved PARP) in three CRC cells when compared with those in the RT+BEZ treatment, RT alone, BEZ alone, and untreated control groups in vitro.In HCT116 xenograft tumor model, RT+BEZ+mBEZ treatment significantly reduced the tumor size than RT+BEZ treatment, RT alone, BEZ alone and control groups.Furthermore, compared with the RT+BEZ treatment, RT alone, BEZ alone and control groups, the expression of p-eIF4E, p-rpS6, and p-ATM was significantly downregulated in the RT+BEZ+mBEZ group both in vitro and in vivo studies.The angiogenesis-related VEGF-A expression in the HCT116 xenograft tumor cells and in three CRC cells were also significantly downregulated in the RT+BEZ+mBEZ treatment group. ConclusionMaintenance BEZ235 treatment in CRC cells prolonged the inhibition of cell viability, enhancement of apoptosis, attenuation of mTOR signaling, impairment of DNA DSB repair mechanism, and downregulation of angiogenesis of concurrent BZE235 and RT.